Colonial Trust Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.1K | Buy |
694
+74
| +12% | +$7.09K | ﹤0.01% | 327 |
|
|
2025
Q4 | $59.6K | Sell |
620
-94
| -13% | -$9.13K | ﹤0.01% | 326 |
|
|
2025
Q3 | $68K | Buy |
714
+11
| +2% | +$1.01K | 0.01% | 302 |
|
|
2025
Q2 | $61.3K | Buy |
703
+10
| +1% | +$848 | 0.01% | 312 |
|
|
2025
Q1 | $62.2K | Buy |
693
+141
| +26% | +$12.6K | 0.01% | 310 |
|
|
2024
Q4 | $44.1K | Sell |
552
-39
| -7% | -$3.38K | ﹤0.01% | 329 |
|
|
2024
Q3 | $53.2K | Hold |
591
| – | – | ﹤0.01% | 328 |
|
|
2024
Q2 | $46.5K | Sell |
591
-66
| -10% | -$5.41K | ﹤0.01% | 331 |
|
|
2024
Q1 | $57.3K | Sell |
657
-121
| -16% | -$10.3K | 0.01% | 308 |
|
|
2023
Q4 | $64.1K | Sell |
778
-87
| -10% | -$6.63K | 0.01% | 287 |
|
|
2023
Q3 | $67.8K | Buy |
865
+1
| +0.1% | +$84 | 0.01% | 297 |
|
|
2023
Q2 | $76.1K | Buy |
864
+1
| +0.1% | +$86 | 0.01% | 284 |
|
|
2023
Q1 | $69.6K | Sell |
863
-107
| -11% | -$8.72K | 0.01% | 295 |
|
|
2022
Q4 | $75.4K | Sell |
970
-117
| -11% | -$9.48K | 0.01% | 280 |
|
|
2022
Q3 | $88K | Buy |
+1,087
| New | +$97.7K | 0.01% | 220 |
|
|
2022
Q1 | – | Sell |
-2,013
| Closed | -$208K | – | 184 |
|
|
2021
Q4 | $208K | Sell |
2,013
-1,157
| -36% | -$134K | 0.02% | 178 |
|
|
2021
Q3 | $397K | Buy |
3,170
+69
| +2% | +$8.93K | 0.05% | 151 |
|
|
2021
Q2 | $385K | Sell |
3,101
-43,673
| -93% | -$5.48M | 0.05% | 153 |
|
|
2021
Q1 | $5.53M | Buy |
46,774
+357
| +0.8% | +$41.8K | 0.73% | 46 |
|
|
2020
Q4 | $5.44M | Buy |
46,417
+1,013
| +2% | +$112K | 0.75% | 43 |
|
|
2020
Q3 | $4.72M | Buy |
45,404
+530
| +1% | +$53.2K | 0.74% | 41 |
|
|
2020
Q2 | $4.12M | Buy |
44,874
+2,303
| +5% | +$221K | 0.7% | 46 |
|
|
2020
Q1 | $3.84M | Buy |
42,571
+2,956
| +7% | +$314K | 0.8% | 37 |
|
|
2019
Q4 | $4.49M | Buy |
39,615
+138
| +0.3% | +$15.1K | 0.75% | 48 |
|
|
2019
Q3 | $4.29M | Buy |
39,477
+4,004
| +11% | +$418K | 0.76% | 49 |
|
|
2019
Q2 | $3.46M | Buy |
35,473
+764
| +2% | +$69.8K | 0.63% | 54 |
|
|
2019
Q1 | $3.16M | Buy |
34,709
+3,760
| +12% | +$337K | 0.6% | 52 |
|
|
2018
Q4 | $2.81M | Sell |
30,949
-725
| -2% | -$67.8K | 0.69% | 49 |
|
|
2018
Q3 | $3.12M | Buy |
31,674
+837
| +3% | +$77.4K | 0.58% | 57 |
|
|
2018
Q2 | $2.64M | Sell |
30,837
-130
| -0.4% | -$10.9K | 0.52% | 57 |
|
|
2018
Q1 | $2.48M | Sell |
30,967
-9,582
| -24% | -$790K | 0.51% | 61 |
|
|
2017
Q4 | $3.27M | Buy |
40,549
+10,584
| +35% | +$848K | 0.51% | 62 |
|
|
2017
Q3 | $2.33M | Buy |
29,965
+887
| +3% | +$73.6K | 0.51% | 63 |
|
|
2017
Q2 | $2.58M | Buy |
29,078
+8,799
| +43% | +$742K | 0.59% | 58 |
|
|
2017
Q1 | $1.68M | Buy |
20,279
+11,531
| +132% | +$901K | 0.52% | 64 |
|
|
2016
Q4 | $623K | Buy |
8,748
+142
| +2% | +$11.2K | 0.2% | 95 |
|
|
2016
Q3 | $744K | Buy |
8,606
+75
| +0.9% | +$6.54K | 0.23% | 92 |
|
|
2016
Q2 | $740K | Sell |
8,531
-99
| -1% | -$8.01K | 0.24% | 89 |
|
|
2016
Q1 | $647K | Sell |
8,630
-150
| -2% | -$11.3K | 0.21% | 91 |
|
|
2015
Q4 | $675K | Sell |
8,780
-75
| -0.8% | -$5.65K | 0.22% | 90 |
|
|
2015
Q3 | $593K | Buy |
8,855
+750
| +9% | +$55.2K | 0.2% | 94 |
|
|
2015
Q2 | $601K | Buy |
8,105
+825
| +11% | +$63K | 0.19% | 100 |
|
|
2015
Q1 | $568K | Buy |
7,280
+3,035
| +71% | +$230K | 0.17% | 102 |
|
|
2014
Q4 | $306K | Sell |
4,245
-505
| -11% | -$35.1K | 0.12% | 115 |
|
|
2014
Q3 | $294K | Buy |
+4,750
| New | +$302K | 0.09% | 123 |
|
Other funds holding MDT
VCM
VPM
Colonial Trust Advisors's MDT Position: Q1 2026 in Review
Colonial Trust Advisors increased its Medtronic (MDT) stake by 12% in Q1 2026, buying an estimated $7.09K and bringing the position to 694 shares worth $60.1K. The position accounts for ﹤0.01% of the portfolio, ranked #327.
Colonial Trust Advisors first reported a position in MDT in Q3 2014 and has held it in 45 quarters since. The position peaked at $5.53M in Q1 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Colonial Trust Advisors held 694 shares of Medtronic worth $60.1K as of Q1 2026.
- Colonial Trust Advisors bought 74 Medtronic shares in Q1 2026, an estimated $7.09K.
- Medtronic made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #327 holding.
- Colonial Trust Advisors first reported a position in Medtronic in Q3 2014 and has held it in 45 quarters since.
- Colonial Trust Advisors's Medtronic position peaked at $5.53M in Q1 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.